Skip to main content
Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
7.49
+0.25 (3.45%)
At close: Oct 29, 2024, 4:00 PM
7.50
+0.01 (0.10%)
After-hours: Oct 29, 2024, 7:20 PM EDT

Aurinia Pharmaceuticals Revenue

Aurinia Pharmaceuticals had revenue of $57.19M in the quarter ending June 30, 2024, with 37.83% growth. This brings the company's revenue in the last twelve months to $207.11M, up 29.35% year-over-year. In the year 2023, Aurinia Pharmaceuticals had annual revenue of $175.51M with 30.95% growth.

Revenue (ttm)
$207.11M
Revenue Growth
+29.35%
P/S Ratio
5.19
Revenue / Employee
$690,350
Employees
300
Market Cap
1.07B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023175.51M41.48M30.95%
Dec 31, 2022134.03M88.43M193.89%
Dec 31, 202145.61M-4.51M-9.00%
Dec 31, 202050.12M49.80M15,660.38%
Dec 31, 2019318.00K-145.00K-31.32%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
agilon health 5.28B
Pediatrix Medical Group 2.00B
Phreesia 389.96M
Evolus 237.26M
BioLife Solutions 139.96M
Vir Biotechnology 78.88M
Immatics 75.94M
IGM Biosciences 2.91M
Revenue Rankings

AUPH News

More News